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Comunicación: 
Osteoarthritis (OA) is one of the most common degenerative joint disease and is characterized by 
a progressive degradation of articular cartilage extracellular matrix (ECM) leading to loss of joint 
mobility and function, accompanied by chronic pain. Currently used therapies for cartilage repair 
are still far from generating regenerated tissue with quality and stability comparable to native 
cartilage. 
We hypothesize that alterations of chondrocyte-ECM interactions in OA affect the expression of 
cell surface adhesion molecules and phage display can allow the identification of high affinity 
peptides by screening peptide libraries against these targets. Here, we report the use of phage 
display to identify novel peptides which specifically bind to human chondrocytes isolated from 
patients with OA.  
Chondrocytes were isolated from healthy and osteoarthritic cartilage obtained from patients 
undergoing partial knee arthroplasty and characterized, in terms of expression of cell surface 
proteins and expression of chondrocyte-specific genes, before the panning experiments to assess 
their phenotypic stage. A phage library displaying random 12-amino acid peptides was first 
incubated with chondrocytes from healthy donors (control cells) and then with osteoarthritic 
chondrocytes. A 12-amino acid peptide (GFQMISNNVYMR) was identified, showing high affinity to 
osteoarthritic chondrocyte cells (about 8-fold higher than the wild-type phage lacking 
recombinant peptides - control).  
Bioinformatics analysis was performed by creating a protein structure database of known and 
stereo-chemical validated OA-associated cell membrane proteins. Protein-peptide docking 
revealed, from the overall complex stability, solvent accessibility and binding site prediction that 
the membrane protein MMP28 is expected to be the putative receptor of the identified peptide 
ligand. 
Future work will be devoted to integrate the identified peptide sequence into nanocarrier 
systems to provide localization of therapeutic molecules into OA cartilage. If successful, these 
nanocarriers can offer important insights into the regenerative mechanisms of cartilage and could 
be applied for developing more efficient and less invasive therapies for treating OA. 
